Page 8 of articles about pcv2
Effect of porcine circovirus type 2 vaccine on postweaning performance and carcass composition
Outcome of porcine circovirus type 1 (PCV1) infections in mid-gestational porcine foetuses
PRRSV enhances PCV2a and PCV2b replication and duration of shedding
Oral fluids - Sampling
Over the last several years, new sampling, monitoring and diagnostic tools for the swine industry that are faster, simpler and more cost effective have been developed and validated. One of these techniques is the sampling and use of oral fluids (saliva) as specimens for diagnostics in swine.
Circovirus vaccination in pigs with subclinical porcine circovirus type 2 infection complicated by ileitis
New Fostera PCV is the only single-dose vaccine that helps prevent PCV2 viremia
Establishment and maintenance of a PCV2-free breeding herd on a site after PCV2-associated reproductive disease
Impact of selected parameters on efficacy of pen based oral fluid collection from pigs
Disinfection protocols reduce the amount of porcine circovirus type 2 in contaminated 1:61 scale model livestock transport vehicles
Boehringer Ingelheim satellite symposium highlights PCV2 landmarks
BacuCheck ELISA test checks PORCILIS PCV vaccination compliance
Theoretical and experimental approaches to estimate the usefulness of pooled serum samples for the diagnosis of postweaning multisystemic wasting syndrome
Field study confirms protection of piglets against porcine circovirus associated disease by vaccination with Porcilis® PCV
The importance of porcine circovirus type 2 (PCV2) subclinical infection
Available data indicate that PCV2 has the ability to modulate the immune response, not only during the obvious overt disease but also in a subclinically infection.
Maternally derived antibodies at the time of porcine circovirus type 2 vaccination: does it matter?
One issue is to overcome maternal immunity, which is true for all PCV2 vaccines in the market, and another is whether the most from these vaccines is achieved independently of the PCV2 antibody titre at vaccination